e-learning
resources
Berlin 2008
Wednesday, 08.10.2008
Genetics, immunology and microbiology of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparison of Nramp1 gene polymorphisms among tuberculosis healthy workers with positive PPD and recently infected cases; host susceptibility to tuberculosis
P. Farnia, S. Anoosheh, O. Pajand, M. R. Masjedi, P. Tabarsi, M. Kazampour, F. Mohammadi, P. Baghei, M. Bahadori, A. A. Velayati (Tehran, Islamic Republic Of Iran)
Source:
Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Session:
Genetics, immunology and microbiology of tuberculosis
Session type:
E-Communication Session
Number:
4533
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Farnia, S. Anoosheh, O. Pajand, M. R. Masjedi, P. Tabarsi, M. Kazampour, F. Mohammadi, P. Baghei, M. Bahadori, A. A. Velayati (Tehran, Islamic Republic Of Iran). Comparison of Nramp1 gene polymorphisms among tuberculosis healthy workers with positive PPD and recently infected cases; host susceptibility to tuberculosis. Eur Respir J 2008; 32: Suppl. 52, 4533
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Paul Kelly - 07.10.2008 10:39
P Kelly
We still do not have a clear predictor or explanation as to why one individual progresses to active TB, following infection while the majority do not.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Expression of the PDCD1 gene to determine active tuberculosis infection in children and adolescents with latent TB infection
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020
The peculiarities of drug susceptibility of M. tuberculosis isolated from patients with late-stage HIV infection
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
Induction of M. tuberculosis (MTB) drug resistance (DR) mutations in HIV-infected hosts and pathways of further spread of the evolutionary successful drug-resistant MTB clonal lines
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Deficient
in silico
selection of
mycobacterium tuberculosis
(MTB) epitopes in tuberculosis (TB) patients
Source: Eur Respir J 2006; 28: Suppl. 50, 801s
Year: 2006
Cytokine gene polymorphisms and
mycobacterium tuberculosis
: from infection to pulmonary disease
Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection
Year: 2006
Different genetics background of patients with latent tuberculosis infection versus active tuberculosis
Source: International Congress 2017 – Asthma genetics and genomics in patients and populations
Year: 2017
Increased frequencies of pulmonary regulatory T-cells in latent Mycobacterium tuberculosis infection
Source: Eur Respir J 2012; 40: 1450-1457
Year: 2012
Impact of T-SPOT.
TB
test to exclude active
Mycobacterium tuberculosis
complex infection in patients with mycobacterial disease
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006
New skin test with recombinant protein CFP10-ESAT6 in patients (children and adults) with tuberculosis, non-tuberculosis disease and latent TB infection
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
Response to
M. tuberculosis
selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
Mycobacterium tuberculosis resistance profiles in index and secondary TB cases from the same household
Source: International Congress 2018 – Challenges in tuberculosis care
Year: 2018
Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts.
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Molecular analysis of mutations in genes associated with multidrug-resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Moscow region, Russia
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018
Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
Estimation of susceptibility hospital strains of Mycobacterium tuberculosis (Mtb) Beijing to disinfectants
Source: International Congress 2017 – Paediatric TB: MDRTB (II)
Year: 2017
Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019
Genetic diversity of M. tuberculosis isolates from patients with drug-resistant TB in Japan
Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity
Year: 2018
Detection of isoniazid or rifampin resistant
Mycobacterium tuberculosis
in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept